Inflammatory biomarkers at different stages of Sarcopenia in older women

[1]  H. Costa,et al.  Adiponectin Is a Contributing Factor of Low Appendicular Lean Mass in Older Community-Dwelling Women: A Cross-Sectional Study , 2022, Journal of clinical medicine.

[2]  M. Schulze,et al.  Frailty is characterized by biomarker patterns reflecting inflammation or muscle catabolism in multi‐morbid patients , 2022, Journal of cachexia, sarcopenia and muscle.

[3]  E. Roh,et al.  Association of plasma brain-derived neurotrophic factor levels and frailty in community-dwelling older adults , 2022, Scientific Reports.

[4]  A. Sayer,et al.  Sarcopenia definition, diagnosis and treatment: consensus is growing , 2022, Age and ageing.

[5]  Tiantian Wang,et al.  Searching for the link between inflammaging and sarcopenia , 2022, Ageing Research Reviews.

[6]  C. Celis-Morales,et al.  Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysis , 2021, Journal of cachexia, sarcopenia and muscle.

[7]  Wen-qing Xie,et al.  Inflammation and sarcopenia: A focus on circulating inflammatory cytokines , 2021, Experimental Gerontology.

[8]  E. D. de Oliveira,et al.  Prevalence of sarcopenia according to EWGSOP1 and EWGSOP2 in older adults and their associations with unfavorable health outcomes: a systematic review , 2021, Aging Clinical and Experimental Research.

[9]  H. Costa,et al.  Inflammatory and oxidative biomarkers as determinants of functional capacity in patients with COPD assessed by 6-min walk test-derived outcomes , 2021, Experimental Gerontology.

[10]  I. Narita,et al.  Brain‐derived neurotrophic factor is associated with sarcopenia and frailty in Japanese hemodialysis patients , 2020, Geriatrics & gerontology international.

[11]  L. C. Pomatto,et al.  Sarcopenia – Molecular mechanisms and open questions , 2020, Ageing Research Reviews.

[12]  Douglas K. Miller,et al.  Serum progranulin levels are associated with frailty in middle-aged individuals , 2020, PloS one.

[13]  R. Heshmat,et al.  Comparison of EWGSOP-1and EWGSOP-2 diagnostic criteria on prevalence of and risk factors for sarcopenia among Iranian older people: the Bushehr Elderly Health (BEH) program , 2020, Journal of Diabetes & Metabolic Disorders.

[14]  I. Benseñor,et al.  Association of sarcopenia with performance in multiple cognitive domains: results from the ELSA-Brasil study. , 2019, The journals of gerontology. Series A, Biological sciences and medical sciences.

[15]  E. Ferri,et al.  The Biological Foundations of Sarcopenia: Established and Promising Markers , 2019, Front. Med..

[16]  E. Rahme,et al.  Physical function‐derived cut‐points for the diagnosis of sarcopenia and dynapenia from the Canadian longitudinal study on aging , 2019, Journal of cachexia, sarcopenia and muscle.

[17]  René Rizzoli,et al.  Sarcopenia: revised European consensus on definition and diagnosis , 2018, Age and ageing.

[18]  H. Costa,et al.  Effects of the inspiratory muscle training and aerobic training on respiratory and functional parameters, inflammatory biomarkers, redox status and quality of life in hemodialysis patients: A randomized clinical trial , 2018, PloS one.

[19]  J. Clarys,et al.  Dual energy X‐ray absorptiometry: gold standard for muscle mass? , 2018, Journal of cachexia, sarcopenia and muscle.

[20]  M. Hashizume,et al.  Relationships between serum brain‐derived neurotrophic factor concentration and parameters for health scores in community‐dwelling older adults , 2018, Geriatrics & gerontology international.

[21]  C. Cooper,et al.  Pitfalls in the measurement of muscle mass: a need for a reference standard , 2018, Journal of cachexia, sarcopenia and muscle.

[22]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[23]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[24]  D. S. Pereira,et al.  Comparison between parameters of muscle performance and inflammatory biomarkers of non-sarcopenic and sarcopenic elderly women , 2017, Clinical interventions in aging.

[25]  Jeffrey K Aronson,et al.  Biomarkers—A General Review , 2017, Current protocols in pharmacology.

[26]  N. Henschke,et al.  Prevalence of sarcopenia in older Brazilians: A systematic review and meta‐analysis , 2017, Geriatrics & gerontology international.

[27]  P. Abete,et al.  Biomarkers in sarcopenia: A multifactorial approach , 2016, Experimental Gerontology.

[28]  S. Shinkai,et al.  Sarcopenia: Prevalence and associated factors based on different suggested definitions in community‐dwelling older adults , 2016, Geriatrics & gerontology international.

[29]  E. Papathanassoglou,et al.  May BDNF Be Implicated in the Exercise-Mediated Regulation of Inflammation? Critical Review and Synthesis of Evidence , 2015, Biological research for nursing.

[30]  A. Kalinkovich,et al.  Sarcopenia – The search for emerging biomarkers , 2015, Ageing Research Reviews.

[31]  Sarah M. Greising,et al.  Ageing and neurotrophic signalling effects on diaphragm neuromuscular function , 2015, The Journal of physiology.

[32]  Maren S Fragala,et al.  The FNIH Sarcopenia Project: Rationale, Study Description, Conference Recommendations, and Final Estimates , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

[33]  B. de Luxán-Delgado,et al.  Interleukin 6, soluble tumor necrosis factor receptor I and red blood cell distribution width as biological markers of functional dependence in an elderly population: a translational approach. , 2012, Cytokine.

[34]  A. Newman,et al.  Inflammatory markers in population studies of aging , 2011, Ageing Research Reviews.

[35]  J. Baeyens,et al.  Sarcopenia: European consensus on definition and diagnosis , 2010, Age and ageing.

[36]  S. Rubin,et al.  Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength. , 2009, The journals of gerontology. Series A, Biological sciences and medical sciences.

[37]  L. Ferrucci,et al.  A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. , 1994, Journal of gerontology.

[38]  Sonia Maria Dozzi Brucki,et al.  O Mini-Exame do Estado Mental em uma população geral: impacto da escolaridade , 1994 .

[39]  A. Lacerda,et al.  Inflammation Biomarkers Are Independent Contributors to Functional Performance in Chronic Conditions: An Exploratory Study , 2021, International Journal of Medical Science and Health Research.

[40]  R. Heshmat,et al.  THE TRABECULAR BONE SCORE IS ASSOCIATED WITH BONE MINERAL DENSITY, AND MARKERS OF BONE TURNOVER IN NON-OBESE SUBJECTS: THE BUSHEHR ELDERLY HEALTH (BEH) PROGRAM , 2020 .

[41]  Chia-Wen Lu,et al.  A cross sectional study , 2019 .

[42]  M. L. Lebrão,et al.  Prevalence and associated factors of sarcopenia, dynapenia, and sarcodynapenia in community-dwelling elderly in São Paulo - SABE Study. , 2019, Revista brasileira de epidemiologia = Brazilian journal of epidemiology.

[43]  J. J. Woo.  A Multifactorial Approach , 2016 .

[44]  J. Baeyens,et al.  European working group on sarcopenia in older people. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people , 2010 .

[45]  E. Glaser.  The randomized clinical trial. , 1972, The New England journal of medicine.

[46]  rancesco,et al.  Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People . Sarcopenia: European consensus on definition and diagnosis: Report the European Working Group on Sarcopenia in Older People. , 2022 .